Developmental Research Program
发展研究计划
基本信息
- 批准号:8556458
- 负责人:
- 金额:$ 5.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-20 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:Applied ResearchAwardBasic ScienceCollaborationsCutaneousDevelopmentEvaluationFloridaFundingGoalsGrantInstitutionLeadLeadershipLinkLungMalignant NeoplasmsMentorsModelingOncologyPeer ReviewPilot ProjectsPreventionPrincipal InvestigatorProcessProgram Research Project GrantsResearchResearch PersonnelSkinSkin CancerStudy SectionSurgical OncologistSystemTrainingUnited States National Institutes of Healthbasedata qualityexpectationinnovationmeetingsmemberprogramssuccess
项目摘要
This Developmental Research Program (DRP) will promote the exploration of innovative ideas in translational cutaneous malignancy research through the funding of pilot projects proposed by Moffitt investigators; it will not support extensions of existing full projects. Dr. Vernon Sondak will lead the DRP. He has been a member of NCI Subcommittee G (training grants) and was the Principal Investigator of the first Pre-SPORE grant awarded by the State of Florida. He has mentored dozens of surgical oncologists and is known as an outstanding mentor. To maximize the likelihood that funded projects will be able to serve as replacement projects if needed, the DRP will support the establishment of new collaborations as well as facilitate either a talented investigator in another relevant field, i.e. a new investigator to cutaneous oncology, to become involved in cutaneous malignancy research or promote promising early research by an investigator already established in the cutaneous malignancy field. An innovative feature of the DRP is that investigators will be encouraged to propose projects that, while based at Moffitt, might involve a collaboration with an established Skin SPORE project at another Skin SPORE institution, or with the existing Moffitt Lung SPORE. In collaboration with the Moffitt Lung SPORE, up to one DRP award per year will be co-supported by the Skin SPORE as a cross-SPORE interaction. DRP projects that link to an ongoing Moffitt Skin SPORE project are encouraged. The DRP will provide guidance, advice, evaluation, and funding for up to three pilot projects per year. The goal for each pilot project is to generate sufficient high-quality data in the field of cutaneous malignancy prevention, treatment, basic research, or applied research to allow for submission of an independent project to the NIH or other federal agency for peer review funding. In addition, developmental projects could serve as potential replacement projects elevated to full project status if an existing full project is completed or fails to meet its translational goals and expectations as determined by the Skin SPORE External Advisory Board (EAB) in conjunction with the leadership of this Skin SPORE. The selection of DRP projects for funding by the Award Evaluation Committee (AEC) will be modeled after the NIH study section review process. The AEC will be chaired Dr. Vernon Sondak. Each pilot project will have three reviewers, a primary reviewer, a secondary reviewer, and a statistical reviewer. The three reviewers will be asked to assign priority scores from 1.0 to 9.0 to the project using the NIH scoring system. Projects from investigators new to cutaneous oncology will be given a high priority.
该发展研究计划(DRP)将通过资助莫菲特研究者提出的试点项目,促进转化性皮肤恶性肿瘤研究中创新思想的探索;它不会支持现有完整项目的扩展。弗农·桑达克博士将领导灾难救援队。他是NCI小组委员会G(培训赠款)的成员,也是佛罗里达州颁发的第一个Pre-SPORE补助金的主要研究员。他指导了数十名外科肿瘤学家,被称为杰出的导师。为了最大限度地提高资助项目在需要时能够作为替代项目的可能性,DRP将支持建立新的合作关系,并促进另一个相关领域的有才华的研究者,即皮肤肿瘤学的新研究者,参与皮肤恶性肿瘤研究或促进皮肤恶性肿瘤领域已有研究者的有前途的早期研究。DRP的一个创新特点是,将鼓励研究者提出项目,而在莫菲特,可能涉及与一个既定的皮肤孢子项目在另一个皮肤孢子机构,或与现有的莫菲特肺孢子合作。与Moffitt Lung SPORE合作,每年最多一个DRP奖项将由Skin SPORE作为跨SPORE互动共同支持。鼓励与正在进行的Moffitt Skin SPORE项目相关的DRP项目。DRP将为每年最多三个试点项目提供指导、建议、评估和资金。每个试点项目的目标是在皮肤恶性肿瘤预防、治疗、基础研究或应用研究领域产生足够的高质量数据,以允许向NIH或其他联邦机构提交独立项目,以获得同行评审资金。此外,如果现有的完整项目已完成或未能达到Skin SPORE外部咨询委员会(EAB)与Skin SPORE领导层共同确定的转化目标和预期,则开发项目可作为提升至完整项目状态的潜在替代项目。由奖励评估委员会(AEC)资助的DRP项目的选择将仿照NIH研究部分的审查过程。原子能委员会将由弗农·桑达克博士主持。每个试点项目将有三名审查员,一名主要审查员,一名次要审查员和一名统计审查员。将要求三位评审员使用NIH评分系统为项目分配1.0至9.0的优先级评分。新的皮肤肿瘤学研究者的项目将被给予高度优先考虑。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VERNON K. SONDAK其他文献
VERNON K. SONDAK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VERNON K. SONDAK', 18)}}的其他基金
MELANOMA VACCINE--TYROSINASE/GP100 W/ MONTANIDE ISA51 OR GM CSF
黑色素瘤疫苗 - 酪氨酸酶/GP100 W/ Montanide ISA51 或 GM CSF
- 批准号:
6303499 - 财政年份:1999
- 资助金额:
$ 5.64万 - 项目类别:
ADOPTIVE CELL THERAPY OF SOFT TISSUE SARCOMAS USING AUTOLOGOUS TUMOR VACCINATION
使用自体肿瘤疫苗接种软组织肉瘤的过继细胞疗法
- 批准号:
6297203 - 财政年份:1998
- 资助金额:
$ 5.64万 - 项目类别:
ADOPTIVE CELL THERAPY OF SOFT TISSUE SARCOMAS USING AUTOLOGOUS TUMOR VACCINATION
使用自体肿瘤疫苗接种软组织肉瘤的过继细胞疗法
- 批准号:
6113552 - 财政年份:1998
- 资助金额:
$ 5.64万 - 项目类别:
MELANOMA VACCINE--TYROSINASE/GP100 W/ MONTANIDE ISA51 OR GM CSF
黑色素瘤疫苗 - 酪氨酸酶/GP100 W/ Montanide ISA51 或 GM CSF
- 批准号:
6297069 - 财政年份:1998
- 资助金额:
$ 5.64万 - 项目类别:
MELANOMA VACCINE--TYROSINASE/GP100 W/ MONTANIDE ISA51 OR GM CSF
黑色素瘤疫苗 - 酪氨酸酶/GP100 W/ Montanide ISA51 或 GM CSF
- 批准号:
6263712 - 财政年份:1998
- 资助金额:
$ 5.64万 - 项目类别:
ADOPTIVE CELL THERAPY OF SOFT TISSUE SARCOMAS USING AUTOLOGOUS TUMOR VACCINATION
使用自体肿瘤疫苗接种软组织肉瘤的过继细胞疗法
- 批准号:
6274786 - 财政年份:1997
- 资助金额:
$ 5.64万 - 项目类别:
相似海外基金
NSF Engines Development Award: Utilizing space research, development and manufacturing to improve the human condition (OH)
NSF 发动机发展奖:利用太空研究、开发和制造来改善人类状况(OH)
- 批准号:
2314750 - 财政年份:2024
- 资助金额:
$ 5.64万 - 项目类别:
Cooperative Agreement
NSF Engines Development Award: Building an sustainable plastics innovation ecosystem in the Midwest (MN, IL)
NSF 引擎发展奖:在中西部(明尼苏达州、伊利诺伊州)建立可持续塑料创新生态系统
- 批准号:
2315247 - 财政年份:2024
- 资助金额:
$ 5.64万 - 项目类别:
Cooperative Agreement
NSF Engines Development Award: Creating climate-resilient opportunities for plant systems (NC)
NSF 发动机开发奖:为工厂系统创造气候适应机会 (NC)
- 批准号:
2315399 - 财政年份:2024
- 资助金额:
$ 5.64万 - 项目类别:
Cooperative Agreement
International Partnering Award: Using AI to assess senescence and mitochondrial morphology in calcifying VSMCs
国际合作奖:利用人工智能评估钙化 VSMC 的衰老和线粒体形态
- 批准号:
BB/Y513982/1 - 财政年份:2024
- 资助金额:
$ 5.64万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Durham University
2024 年开放访问区块奖 - 杜伦大学
- 批准号:
EP/Z531480/1 - 财政年份:2024
- 资助金额:
$ 5.64万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Goldsmiths College
2024 年开放获取区块奖 - 金史密斯学院
- 批准号:
EP/Z531509/1 - 财政年份:2024
- 资助金额:
$ 5.64万 - 项目类别:
Research Grant
Open Access Block Award 2024 - John Innes Centre
2024 年开放访问区块奖 - 约翰·英尼斯中心
- 批准号:
EP/Z53156X/1 - 财政年份:2024
- 资助金额:
$ 5.64万 - 项目类别:
Research Grant
Open Access Block Award 2024 - London School of Economics & Pol Sci
2024 年开放获取区块奖 - 伦敦政治经济学院
- 批准号:
EP/Z531625/1 - 财政年份:2024
- 资助金额:
$ 5.64万 - 项目类别:
Research Grant
Open Access Block Award 2024 - Oxford Brookes University
2024 年开放获取区块奖 - 牛津布鲁克斯大学
- 批准号:
EP/Z531728/1 - 财政年份:2024
- 资助金额:
$ 5.64万 - 项目类别:
Research Grant
Open Access Block Award 2024 - The Francis Crick Institute
2024 年开放获取区块奖 - 弗朗西斯·克里克研究所
- 批准号:
EP/Z531844/1 - 财政年份:2024
- 资助金额:
$ 5.64万 - 项目类别:
Research Grant














{{item.name}}会员




